Delivery Order SPE2DB22D2211-SPE2DB25FSDMM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,575.54 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on August 4, 2025, with completion targeted for August 5, 2025. This non-competitive, firm fixed-price delivery order represents a single transaction within AmerisourceBergen's larger federal pharmaceutical supply relationship. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,430.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.84 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside contract utilizing an existing contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $11,592.37 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 15 mg/0.5 ml pen injectors with a ceiling value of $20,970.99. This is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $15,184.50 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injectors on July 24, 2025, with completion expected by July 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was issued without set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,518.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle and requires fulfillment within an...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $11,576.35. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 11, 2025. The contract represents a continuation of pharmaceutical supply under AmerisourceBergen's broader relationship with federal medical procurement, with performance to be...
- The Defense Logistics Agency awarded a delivery order valued at $3,154.25 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is issued under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDMMDelivery Order
The Defense Logistics Agency has awarded a $40,331.20 delivery order to AmerisourceBergen Drug Corp for supply of Zepbound 10 mg/0.5 mL pen injectors, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competition process through which AmerisourceBergen was selected. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems, including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices. The company's portfolio of federal contract awards demonstrates consistent capability to meet DLA procurement requirements for diverse therapeutic domains across multiple service regions and customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.3k | 8/22/25 |